Profile data is unavailable for this security.
About the company
CANbridge Pharmaceuticals Inc is a China-based company mainly engaged in the research, development and commercialization of rare disease treatments. The Company's main businesses are the development, production, promotion and sales of medical products. The Company's main product is the glycosylated fusion protein CAN008 for the treatment of glioblastoma (GBM). The Company's products are mainly used in rare diseases such as Hunter's syndrome (MPS II), rare tumors and other fields. The Company is also engaged in the development of gene therapy.
- Revenue in HKD (TTM)114.24m
- Net income in HKD-445.49m
- Incorporated2017
- Employees93.00
- LocationCANbridge Pharmaceuticals IncRongchuang Roadchaoyang DistrictSuite 301, 3f, Timeloit No.17SUZHOU 02142-1530ChinaCHN
- Phone+86 1 084148018
- Fax+86 1 084148017
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China NT Pharma Group Co Ltd | 34.18m | -30.61m | 91.11m | 20.00 | -- | -- | -- | 2.67 | -0.162 | -0.7665 | 0.1635 | -1.43 | 0.0449 | -- | 1.84 | 2,136,092.00 | -4.02 | -12.34 | -- | -163.52 | 18.23 | -- | -89.57 | -128.28 | -- | -- | 35.06 | -- | -- | -58.12 | 33.07 | -- | -46.32 | -- |
| Sanai Health Industry Group Co Ltd | 106.52m | 14.26m | 97.86m | 156.00 | 7.26 | 0.2753 | 9.36 | 0.9187 | 0.0882 | 0.0882 | 0.733 | 2.32 | 0.2261 | 13.97 | 6.37 | 1,566,398.00 | 1.74 | 2.31 | 2.21 | 3.65 | 17.99 | 34.87 | 7.71 | 6.56 | 4.10 | -3.68 | 0.1077 | 0.00 | -30.60 | 16.04 | -36.23 | -- | -75.21 | -- |
| Regent Pacific Group Ltd | 1.98m | -120.25m | 102.80m | 19.00 | -- | -- | -- | 51.86 | -0.5265 | -0.5265 | 0.0087 | -0.1387 | 0.0288 | -- | 11.86 | 116,593.50 | -174.72 | -50.00 | -279.01 | -59.04 | -- | -- | -6,067.06 | -2,685.21 | -- | -152.22 | -- | -- | 574.47 | -44.72 | 31.24 | -- | -50.60 | -- |
| Canbridge Pharmaceuticals Inc | 114.24m | -445.49m | 110.46m | 93.00 | -- | -- | -- | 0.9669 | -1.05 | -1.05 | 0.269 | -0.7204 | 0.2558 | 2.32 | 3.81 | 1,142,424.00 | -99.74 | -- | -1,160.07 | -- | 63.97 | -- | -389.95 | -- | 0.2146 | -44.04 | -- | -- | 30.26 | -- | 21.64 | -- | -- | -- |
| Extrawell Pharmaceutical Holdings Ltd | 59.10m | -162.95m | 119.50m | 159.00 | -- | 0.1074 | -- | 2.02 | -0.0682 | -0.0682 | 0.0247 | 0.4657 | 0.0433 | 5.90 | 11.81 | 371,685.50 | -11.83 | 1.01 | -12.32 | 1.06 | 48.70 | 50.54 | -273.51 | 18.00 | 3.31 | -0.0753 | 0.0977 | 0.00 | -18.57 | -7.91 | -226.06 | -- | -3.20 | -- |
| Modern Chinese Medicine Group Co Ltd | 262.75m | 15.68m | 195.00m | 190.00 | 12.43 | 0.3827 | 8.67 | 0.7421 | 0.0261 | 0.0261 | 0.4379 | 0.8492 | 0.482 | 5.62 | 4.48 | 1,375,669.00 | 2.88 | 20.76 | 3.08 | 25.82 | 27.70 | 41.02 | 5.97 | 20.11 | 10.90 | -- | 0.001 | 2.54 | -13.91 | 14.67 | -44.44 | 0.2303 | 96.96 | -- |
| Kontafarma China Holdings Ltd | 836.92m | -63.24m | 195.60m | 717.00 | -- | 0.1838 | 19.08 | 0.2337 | -0.0113 | -0.0113 | 0.150 | 0.1904 | 0.4756 | 3.52 | 6.67 | 1,162,388.00 | -4.95 | -1.33 | -6.40 | -2.18 | 59.88 | 54.70 | -10.40 | -4.12 | 1.24 | -5.93 | 0.2116 | -- | -9.50 | -17.32 | 66.02 | -- | -19.55 | -- |
| Shenzhen Neptunus Intrlng Bi tchnq CoLtd | 1.15bn | 35.11m | 216.46m | 1.47k | 6.17 | 0.2095 | 595.25 | 0.1881 | 0.0209 | 0.0209 | 0.6858 | 0.6157 | 0.7383 | 3.11 | 3.99 | 796,970.60 | 1.73 | 3.46 | 2.56 | 5.13 | 37.47 | 49.14 | 2.34 | 4.29 | 2.20 | 29.81 | 0.082 | 0.00 | 7.92 | 4.19 | -55.60 | -12.89 | -11.10 | -- |
| Wai Yuen Tong Medicine Holdings Limited | 783.88m | -26.68m | 227.27m | 810.00 | -- | 0.1706 | 2.78 | 0.2899 | -0.0228 | -0.0132 | 0.6636 | 1.18 | 0.1721 | 0.4001 | 10.55 | 967,754.30 | -0.1597 | -0.3053 | -0.2538 | -0.5206 | 50.37 | 43.82 | -0.928 | -2.18 | 1.37 | 2.13 | 0.2879 | -- | 8.33 | 0.8488 | -62.16 | -- | 15.35 | -- |
| PuraPharm Corp Ltd | 419.41m | -87.09m | 273.17m | 525.00 | -- | 2.09 | -- | 0.6513 | -0.2205 | -0.2205 | 1.06 | 0.3296 | 0.4854 | 1.15 | 5.93 | 633,542.30 | -10.08 | -9.20 | -30.69 | -19.70 | 51.97 | 59.52 | -20.77 | -19.33 | 0.3116 | -1.42 | 0.7597 | -- | -9.20 | -11.41 | 11.76 | -- | -13.68 | -- |
| Hin Sang Group (Interntnl) Hldng Co Ltd | 92.62m | -36.71m | 289.33m | 247.00 | -- | 1.39 | -- | 3.12 | -0.0336 | -0.0336 | 0.0848 | 0.1913 | 0.1536 | 2.34 | 10.34 | 374,967.60 | -6.04 | -5.11 | -9.78 | -7.04 | 61.98 | 59.72 | -39.30 | -28.42 | 0.1287 | -1.68 | 0.6054 | -- | 13.70 | -12.83 | 25.84 | -- | -69.21 | -- |
Data as of Oct 28 2024. Currency figures normalised to CANbridge Pharmaceuticals Inc's reporting currency: Hong Kong Dollar HKD
12.40%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Athos Capital Ltd.as of 15 Dec 2023 | 52.67m | 12.40% |
| Janus Henderson Investors US LLCas of 30 Jun 2024 | 0.00 | 0.00% |
| RA Capital Management LPas of 19 Dec 2023 | 0.00 | 0.00% |
| Janus Henderson Investors UK Ltd.as of 30 Jun 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
